CMC Considerations for siRNA Drug Substance Manufacturing

Time: 3:30 pm
day: Track A Day 1 PM

Details:

  • Quality considerations for conjugates and linkers
  • Challenges of solid-phase synthesis of siRNA’s
  • Impurity profiling of siRNA drug substance

Speakers: